Evaluation of the effects of topical tripeptide-copper complex and zinc oxide on open-wound healing in rabbits
Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis
Water, Butylene Glycol, Glycerin, Niacinamide, 1,2-Hexanediol, Isopentyldiol, Trehalose, Carbomer, Arginine, Allantoin, Panthenol, Ethylhexylglycerin, Polyglyceryl-10 Laurate, Xanthan Gum, Adenosine, Melia Azadirachta (Neem) Leaf Extract, Melia Azadirachta Flower Extract, Disodium EDTA, Glyceryl Acrylate/Acrylic Acid Copolymer, Sodium DNA (PDRN), Coccinia Indica Fruit Extract, Solanum Melongena (Eggplant) Fruit Extract, Ocimum Sanctum Leaf Extract, Propanediol, Curcuma Longa (Turmeric) Root Extract, Corallina Officinalis Extract, Hydrolyzed Hyaluronic Acid, Glyceryl Oleate, Lauryl Glucoside, Myristyl Glucoside, Polyglyceryl-6 Laurate, Hydrogenated Lecithin, Hydrolyzed Collagen, Sodium Hyaluronate, Coptis Japonica Root Extract, Glutathione, Hyaluronic Acid, Hydrolyzed Sodium Hyaluronate, Hydroxypropyltrimonium Hyaluronate, Potassium Hyaluronate, Sodium Hyaluronate Crosspolymer, Citric Acid, Sodium Citrate, Pentylene Glycol, Sodium Acetylated Hyaluronate
Main pathway: VEGFR2 and angiogenesis The best-characterized pharmacological cascade of BPC-157 involves the VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) receptor
Certificate of Analysis for GHK-Cu verifying purity, identity, and quality
